Clearmind Medicine has—and continues to build—a culture of world-leading innovators in novel phsychedelics. Learn more about the team we’ve created so far.

Our CEO

An Experienced Public Company Leader and a Skilled Navigator of Clinical Trial Processes

Adi Zuloff-Shani, PhD

Dr. Adi Zuloff-Shani is a Biomedical Research and Development Executive with a vast experience with over 20 years of strategic and operational leadership in the healthcare industry and a deep understanding of therapeutics development in heavily regulated environments.

Our Team

A focused team of international experts

Mark Haden, MSW

VP Business Development

Sara Horn, PhD

Regulatory Affairs

Alan Rootenberg

Chief Financial Officer

Amit Shwartz, MSc

R&D Consultant

Shannon Smadella

Community Development

Yael Stav, PhD

Program Management

Scientific Advisory Board

An award winning advisory board

Prof. Fatima Cody Stanford

MD, MPH, MPA, Harvard Medical School, MA, US

Prof. Joseph Tam

DMD, PhD, Hebrew University, Israel

Prof. Henry R. Kranzler

MD, PhD, University of Pennsylvania, PA, US

Prof. John Krystal

MD, Yale University, CT, US

Prof. Christian Schütz

MD, PhD, University of British Columbia, Canada

Prof. Gal Yadid

PhD, Bar Ilan University, Israel

Prof. Alon Friedman

MD, PhD, Dalhousie University, Halifax, Canada

Prof. Michael Davidson

MD, Israeli Medical Centre for Alzheimer, Israel

Prof. Wim van den Brink

MD, PhD, University of Amsterdam, The Netherlands

Prof. Gabriele Fischer

MD, PhD, Medical University Vienna, Austria

Our Directors

An experienced board of directors.

Asaf Itzhaik

Asaf Itzhaik

Director

Amitay Weiss

Amitay Weiss

Chairman of the Board

Oz Adler

Oz Adler

Director

Yehonatan Shachar

Yehonatan Shachar

Director

Our Partners

Join Us

Let's Make History

Thank you for sending your contact information—your details have been received.

Oops! Something went wrong. Please try again.